Table of Content



1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Injectable Anticoagulants
1.2 Key Market Segments
1.2.1 Injectable Anticoagulants Segment by Type
1.2.2 Injectable Anticoagulants Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats

2 Injectable Anticoagulants Market Overview
2.1 Global Market Overview
2.1.1 Global Injectable Anticoagulants Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Injectable Anticoagulants Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 Injectable Anticoagulants Market Competitive Landscape
3.1 Global Injectable Anticoagulants Sales by Manufacturers (2017-2022)
3.2 Global Injectable Anticoagulants Revenue Market Share by Manufacturers (2017-2022)
3.3 Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Injectable Anticoagulants Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Injectable Anticoagulants Sales Sites, Area Served, Product Type
3.6 Injectable Anticoagulants Market Competitive Situation and Trends
3.6.1 Injectable Anticoagulants Market Concentration Rate
3.6.2 Global 5 and 10 Largest Injectable Anticoagulants Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion

4 Injectable Anticoagulants Industry Chain Analysis
4.1 Injectable Anticoagulants Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 The Development and Dynamics of Injectable Anticoagulants Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 Injectable Anticoagulants Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Injectable Anticoagulants Sales Market Share by Type (2017-2022)
6.3 Global Injectable Anticoagulants Market Size Market Share by Type (2017-2022)
6.4 Global Injectable Anticoagulants Price by Type (2017-2022)

7 Injectable Anticoagulants Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Injectable Anticoagulants Market Sales by Application (2017-2022)
7.3 Global Injectable Anticoagulants Market Size (M USD) by Application (2017-2022)
7.4 Global Injectable Anticoagulants Sales Growth Rate by Application (2017-2022)

8 Injectable Anticoagulants Market Segmentation by Region
8.1 Global Injectable Anticoagulants Sales by Region
8.1.1 Global Injectable Anticoagulants Sales by Region
8.1.2 Global Injectable Anticoagulants Sales Market Share by Region
8.2 North America
8.2.1 North America Injectable Anticoagulants Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Injectable Anticoagulants Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Injectable Anticoagulants Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Injectable Anticoagulants Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Injectable Anticoagulants Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa

9 Key Companies Profiled
9.1 Sanofi
9.1.1 Sanofi Injectable Anticoagulants Basic Information
9.1.2 Sanofi Injectable Anticoagulants Product Overview
9.1.3 Sanofi Injectable Anticoagulants Product Market Performance
9.1.4 Sanofi Business Overview
9.1.5 Sanofi Injectable Anticoagulants SWOT Analysis
9.1.6 Sanofi Recent Developments
9.2 Genentech (Roche)
9.2.1 Genentech (Roche) Injectable Anticoagulants Basic Information
9.2.2 Genentech (Roche) Injectable Anticoagulants Product Overview
9.2.3 Genentech (Roche) Injectable Anticoagulants Product Market Performance
9.2.4 Genentech (Roche) Business Overview
9.2.5 Genentech (Roche) Injectable Anticoagulants SWOT Analysis
9.2.6 Genentech (Roche) Recent Developments
9.3 Boehringer Ingelheim
9.3.1 Boehringer Ingelheim Injectable Anticoagulants Basic Information
9.3.2 Boehringer Ingelheim Injectable Anticoagulants Product Overview
9.3.3 Boehringer Ingelheim Injectable Anticoagulants Product Market Performance
9.3.4 Boehringer Ingelheim Business Overview
9.3.5 Boehringer Ingelheim Injectable Anticoagulants SWOT Analysis
9.3.6 Boehringer Ingelheim Recent Developments
9.4 Aspen
9.4.1 Aspen Injectable Anticoagulants Basic Information
9.4.2 Aspen Injectable Anticoagulants Product Overview
9.4.3 Aspen Injectable Anticoagulants Product Market Performance
9.4.4 Aspen Business Overview
9.4.5 Aspen Injectable Anticoagulants SWOT Analysis
9.4.6 Aspen Recent Developments
9.5 Pfizer
9.5.1 Pfizer Injectable Anticoagulants Basic Information
9.5.2 Pfizer Injectable Anticoagulants Product Overview
9.5.3 Pfizer Injectable Anticoagulants Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Injectable Anticoagulants SWOT Analysis
9.5.6 Pfizer Recent Developments
9.6 Hepalink
9.6.1 Hepalink Injectable Anticoagulants Basic Information
9.6.2 Hepalink Injectable Anticoagulants Product Overview
9.6.3 Hepalink Injectable Anticoagulants Product Market Performance
9.6.4 Hepalink Business Overview
9.6.5 Hepalink Recent Developments
9.7 King-friend
9.7.1 King-friend Injectable Anticoagulants Basic Information
9.7.2 King-friend Injectable Anticoagulants Product Overview
9.7.3 King-friend Injectable Anticoagulants Product Market Performance
9.7.4 King-friend Business Overview
9.7.5 King-friend Recent Developments
9.8 CSBIO
9.8.1 CSBIO Injectable Anticoagulants Basic Information
9.8.2 CSBIO Injectable Anticoagulants Product Overview
9.8.3 CSBIO Injectable Anticoagulants Product Market Performance
9.8.4 CSBIO Business Overview
9.8.5 CSBIO Recent Developments
9.9 Amphastar Pharmaceuticals
9.9.1 Amphastar Pharmaceuticals Injectable Anticoagulants Basic Information
9.9.2 Amphastar Pharmaceuticals Injectable Anticoagulants Product Overview
9.9.3 Amphastar Pharmaceuticals Injectable Anticoagulants Product Market Performance
9.9.4 Amphastar Pharmaceuticals Business Overview
9.9.5 Amphastar Pharmaceuticals Recent Developments
10 Injectable Anticoagulants Market Forecast by Region
10.1 Global Injectable Anticoagulants Market Size Forecast
10.2 Global Injectable Anticoagulants Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Injectable Anticoagulants Market Size Forecast by Country
10.2.3 Asia Pacific Injectable Anticoagulants Market Size Forecast by Region
10.2.4 South America Injectable Anticoagulants Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Injectable Anticoagulants by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Injectable Anticoagulants Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Injectable Anticoagulants by Type (2022-2028)
11.1.2 Global Injectable Anticoagulants Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Injectable Anticoagulants by Type (2022-2028)
11.2 Global Injectable Anticoagulants Market Forecast by Application (2022-2028)
11.2.1 Global Injectable Anticoagulants Sales (K Units) Forecast by Application
11.2.2 Global Injectable Anticoagulants Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings



List of Figures

?LIST OF TABLES

Table 1. Introduction of the Type

Table 2. Introduction of the Application

Table 3. Market Size (M USD) Segment Executive Summary

Table 4. Injectable Anticoagulants Market Size (M USD) Comparison by Region (M USD)

Table 5. Global Injectable Anticoagulants Sales (K Units) by Manufacturers (2017-2022)

Table 6. Global Injectable Anticoagulants Sales Market Share by Manufacturers (2017-2022)

Table 7. Global Injectable Anticoagulants Revenue (M USD) by Manufacturers (2017-2022)

Table 8. Global Injectable Anticoagulants Revenue Share by Manufacturers (2017-2022)

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anticoagulants as of 2021)

Table 10. Global Market Injectable Anticoagulants Average Price (USD/Unit) of Key Manufacturers (2017-2022)

Table 11. Manufacturers Injectable Anticoagulants Sales Sites and Area Served

Table 12. Manufacturers Injectable Anticoagulants Product Type

Table 13. Global Injectable Anticoagulants Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion Plans

Table 15. Industry Chain Map of Injectable Anticoagulants

Table 16. Raw Materials

Table 17. Midstream Market Analysis

Table 18. Downstream Customer Analysis

Table 19. Key Development Trends

Table 20. Driving Factors

Table 21. Injectable Anticoagulants Market Challenges

Table 22. Market Restraints

Table 23. Global Injectable Anticoagulants Sales by Type (K Units)

Table 24. Global Injectable Anticoagulants Market Size by Type (M USD)

Table 25. Global Injectable Anticoagulants Sales (K Units) by Type (2017-2022)

Table 26. Global Injectable Anticoagulants Sales Market Share by Type (2017-2022)

Table 27. Global Injectable Anticoagulants Market Size (M USD) by Type (2017-2022)

Table 28. Global Injectable Anticoagulants Market Size Share by Type (2017-2022)

Table 29. Global Injectable Anticoagulants Price (USD/Unit) by Type (2017-2022)

Table 30. Global Injectable Anticoagulants Sales (K Units) by Application

Table 31. Global Injectable Anticoagulants Market Size by Application

Table 32. Global Injectable Anticoagulants Sales by Application (2017-2022) & (K Units)

Table 33. Global Injectable Anticoagulants Sales Market Share by Application (2017-2022)

Table 34. Global Injectable Anticoagulants Sales by Application (2017-2022) & (M USD)

Table 35. Global Injectable Anticoagulants Market Share by Application (2017-2022)

Table 36. Global Injectable Anticoagulants Sales Growth Rate by Application (2017-2022)

Table 37. Global Injectable Anticoagulants Sales by Region (2017-2022) & (K Units)

Table 38. Global Injectable Anticoagulants Sales Market Share by Region (2017-2022)

Table 39. North America Injectable Anticoagulants Sales by Country (2017-2022) & (K Units)

Table 40. Europe Injectable Anticoagulants Sales by Country (2017-2022) & (K Units)

Table 41. Asia Pacific Injectable Anticoagulants Sales by Region (2017-2022) & (K Units)

Table 42. South America Injectable Anticoagulants Sales by Country (2017-2022) & (K Units)

Table 43. Middle East and Africa Injectable Anticoagulants Sales by Region (2017-2022) & (K Units)

Table 44. Sanofi Injectable Anticoagulants Basic Information

Table 45. Sanofi Injectable Anticoagulants Product Overview

Table 46. Sanofi Injectable Anticoagulants Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 47. Sanofi Business Overview

Table 48. Sanofi Injectable Anticoagulants SWOT Analysis

Table 49. Sanofi Recent Developments

Table 50. Genentech (Roche) Injectable Anticoagulants Basic Information

Table 51. Genentech (Roche) Injectable Anticoagulants Product Overview

Table 52. Genentech (Roche) Injectable Anticoagulants Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 53. Genentech (Roche) Business Overview

Table 54. Genentech (Roche) Injectable Anticoagulants SWOT Analysis

Table 55. Genentech (Roche) Recent Developments

Table 56. Boehringer Ingelheim Injectable Anticoagulants Basic Information

Table 57. Boehringer Ingelheim Injectable Anticoagulants Product Overview

Table 58. Boehringer Ingelheim Injectable Anticoagulants Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 59. Boehringer Ingelheim Business Overview

Table 60. Boehringer Ingelheim Injectable Anticoagulants SWOT Analysis

Table 61. Boehringer Ingelheim Recent Developments

Table 62. Aspen Injectable Anticoagulants Basic Information

Table 63. Aspen Injectable Anticoagulants Product Overview

Table 64. Aspen Injectable Anticoagulants Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 65. Aspen Business Overview

Table 66. Aspen Injectable Anticoagulants SWOT Analysis

Table 67. Aspen Recent Developments

Table 68. Pfizer Injectable Anticoagulants Basic Information

Table 69. Pfizer Injectable Anticoagulants Product Overview

Table 70. Pfizer Injectable Anticoagulants Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 71. Pfizer Business Overview

Table 72. Pfizer Injectable Anticoagulants SWOT Analysis

Table 73. Pfizer Recent Developments

Table 74. Hepalink Injectable Anticoagulants Basic Information

Table 75. Hepalink Injectable Anticoagulants Product Overview

Table 76. Hepalink Injectable Anticoagulants Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 77. Hepalink Business Overview

Table 78. Hepalink Recent Developments

Table 79. King-friend Injectable Anticoagulants Basic Information

Table 80. King-friend Injectable Anticoagulants Product Overview

Table 81. King-friend Injectable Anticoagulants Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 82. King-friend Business Overview

Table 83. King-friend Recent Developments

Table 84. CSBIO Injectable Anticoagulants Basic Information

Table 85. CSBIO Injectable Anticoagulants Product Overview

Table 86. CSBIO Injectable Anticoagulants Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 87. CSBIO Business Overview

Table 88. CSBIO Recent Developments

Table 89. Amphastar Pharmaceuticals Injectable Anticoagulants Basic Information

Table 90. Amphastar Pharmaceuticals Injectable Anticoagulants Product Overview

Table 91. Amphastar Pharmaceuticals Injectable Anticoagulants Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 92. Amphastar Pharmaceuticals Business Overview

Table 93. Amphastar Pharmaceuticals Recent Developments

Table 94. Global Injectable Anticoagulants Sales Forecast by Region (K Units)

Table 95. Global Injectable Anticoagulants Market Size Forecast by Region (M USD)

Table 96. North America Injectable Anticoagulants Sales Forecast by Country (2022-2028) & (K Units)

Table 97. North America Injectable Anticoagulants Market Size Forecast by Country (2022-2028) & (M USD)

Table 98. Europe Injectable Anticoagulants Sales Forecast by Country (2022-2028) & (K Units)

Table 99. Europe Injectable Anticoagulants Market Size Forecast by Country (2022-2028) & (M USD)

Table 100. Asia Pacific Injectable Anticoagulants Sales Forecast by Region (2022-2028) & (K Units)

Table 101. Asia Pacific Injectable Anticoagulants Market Size Forecast by Region (2022-2028) & (M USD)

Table 102. South America Injectable Anticoagulants Sales Forecast by Country (2022-2028) & (K Units)

Table 103. South America Injectable Anticoagulants Market Size Forecast by Country (2022-2028) & (M USD)

Table 104. Middle East and Africa Injectable Anticoagulants Consumption Forecast by Country (2022-2028) & (Units)

Table 105. Middle East and Africa Injectable Anticoagulants Market Size Forecast by Country (2022-2028) & (M USD)

Table 106. Global Injectable Anticoagulants Sales Forecast by Type (2022-2028) & (K Units)

Table 107. Global Injectable Anticoagulants Market Size Forecast by Type (2022-2028) & (M USD)

Table 108. Global Injectable Anticoagulants Price Forecast by Type (2022-2028) & (USD/Unit)

Table 109. Global Injectable Anticoagulants Sales (K Units) Forecast by Application (2022-2028)

Table 110. Global Injectable Anticoagulants Market Size Forecast by Application (2022-2028) & (M USD)

List of Figures

Figure 1. Product Picture of Injectable Anticoagulants

Figure 2. Data Triangulation

Figure 3. Key Caveats

Figure 4. Global Injectable Anticoagulants Market Size (M USD), 2017-2028

Figure 5. Global Injectable Anticoagulants Market Size (M USD) (2017-2028)

Figure 6. Global Injectable Anticoagulants Sales (K Units) & (2017-2028)

Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 9. Evaluation Matrix of Regional Market Development Potential

Figure 10. Injectable Anticoagulants Market Size (M USD) by Country (M USD)

Figure 11. Injectable Anticoagulants Sales Share by Manufacturers in 2020

Figure 12. Global Injectable Anticoagulants Revenue Share by Manufacturers in 2020

Figure 13. Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 14. Global Market Injectable Anticoagulants Average Price (USD/Unit) of Key Manufacturers in 2020

Figure 15. The Global 5 and 10 Largest Players: Market Share by Injectable Anticoagulants Revenue in 2021

Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 17. Global Injectable Anticoagulants Market Share by Type

Figure 18. Sales Market Share of Injectable Anticoagulants by Type (2017-2022)

Figure 19. Sales Market Share of Injectable Anticoagulants by Type in 2021

Figure 20. Market Size Share of Injectable Anticoagulants by Type (2017-2022)

Figure 21. Market Size Market Share of Injectable Anticoagulants by Type in 2020

Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 23. Global Injectable Anticoagulants Market Share by Application

Figure 24. Global Injectable Anticoagulants Sales Market Share by Application (2017-2022)

Figure 25. Global Injectable Anticoagulants Sales Market Share by Application in 2021

Figure 26. Global Injectable Anticoagulants Market Share by Application (2017-2022)

Figure 27. Global Injectable Anticoagulants Market Share by Application in 2020

Figure 28. Global Injectable Anticoagulants Sales Growth Rate by Application (2017-2022)

Figure 29. Global Injectable Anticoagulants Sales Market Share by Region (2017-2022)

Figure 30. North America Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 31. North America Injectable Anticoagulants Sales Market Share by Country in 2020

Figure 32. U.S. Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 33. Canada Injectable Anticoagulants Sales (K Units) and Growth Rate (2017-2022)

Figure 34. Mexico Injectable Anticoagulants Sales (Units) and Growth Rate (2017-2022)

Figure 35. Europe Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 36. Europe Injectable Anticoagulants Sales Market Share by Country in 2020

Figure 37. Germany Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 38. France Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 39. U.K. Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 40. Italy Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 41. Russia Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 42. Asia Pacific Injectable Anticoagulants Sales and Growth Rate (K Units)

Figure 43. Asia Pacific Injectable Anticoagulants Sales Market Share by Region in 2020

Figure 44. China Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 45. Japan Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 46. South Korea Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 47. India Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 48. Southeast Asia Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 49. South America Injectable Anticoagulants Sales and Growth Rate (K Units)

Figure 50. South America Injectable Anticoagulants Sales Market Share by Country in 2020

Figure 51. Brazil Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 52. Argentina Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 53. Columbia Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 54. Middle East and Africa Injectable Anticoagulants Sales and Growth Rate (K Units)

Figure 55. Middle East and Africa Injectable Anticoagulants Sales Market Share by Region in 2020

Figure 56. Saudi Arabia Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 57. UAE Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 58. Egypt Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 59. Nigeria Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 60. South Africa Injectable Anticoagulants Sales and Growth Rate (2017-2022) & (K Units)

Figure 61. Global Injectable Anticoagulants Sales Forecast by Volume (2017-2028) & (K Units)

Figure 62. Global Injectable Anticoagulants Market Size Forecast by Value (2017-2028) & (M USD)

Figure 63. Global Injectable Anticoagulants Sales Market Share Forecast by Type (2022-2028)

Figure 64. Global Injectable Anticoagulants Market Share Forecast by Type (2022-2028)

Figure 65. Global Injectable Anticoagulants Sales Forecast by Application (2022-2028)

Figure 66. Global Injectable Anticoagulants Market Share Forecast by Application (2022-2028)